<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://healthandtechnow.com/articles/cvs-cigna-openai-computer-use-agents/</loc>
    <news:news>
      <news:publication>
        <news:name>Health and Tech Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T11:08:00-06:00</news:publication_date>
      <news:title>CVS and Cigna use OpenAI agents across clinical systems</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://healthandtechnow.com/articles/glp1-medical-savings-71-percent-drug-costs-year-3-cvs-aetna/</loc>
    <news:news>
      <news:publication>
        <news:name>Health and Tech Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T11:00:00-06:00</news:publication_date>
      <news:title>GLP-1 medical savings covered 71% of drug costs by year 3</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://healthandtechnow.com/articles/apple-health-ai-study-200000-iphone-users-openevidence/</loc>
    <news:news>
      <news:publication>
        <news:name>Health and Tech Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-16T07:08:00-06:00</news:publication_date>
      <news:title>Apple opens health AI study to 200,000 iPhone users</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://healthandtechnow.com/articles/nebraska-medicaid-work-rule-denials-unanswered-notices/</loc>
    <news:news>
      <news:publication>
        <news:name>Health and Tech Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T14:30:00-06:00</news:publication_date>
      <news:title>Nebraska&apos;s Medicaid work rule: 7 denials for unanswered notices for every 1 for failing the rule</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://healthandtechnow.com/articles/fda-approves-gazyva-primary-membranous-nephropathy/</loc>
    <news:news>
      <news:publication>
        <news:name>Health and Tech Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:41:00-06:00</news:publication_date>
      <news:title>FDA approves Gazyva as the first drug for primary membranous nephropathy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://healthandtechnow.com/articles/fda-approves-imfinzi-padcev-bladder-cancer-volga/</loc>
    <news:news>
      <news:publication>
        <news:name>Health and Tech Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:40:00-06:00</news:publication_date>
      <news:title>FDA approves Imfinzi plus Padcev before bladder surgery for patients who cannot take cisplatin</news:title>
    </news:news>
  </url>
</urlset>
